Optigenex Enters Into Supply, License Agreement With Suracell

Optigenex has entered into a supply and license Agreement with Suracell to provide its patented ingredient AC-11 for use in a focused nutritional and age management dietary supplement program.

Reportedly, in the beginning of January 2010, Suracell will be marketing a specific dietary supplement regimen. Participants will complete lifestyle questionnaires and will be asked to provide specimens for testing of key bio markers that will form the basis for a focused nutritional supplement program utilising the diverse line of Suracell formulated products with AC-11.

Daniel Zwiren, president and CEO of Optigenex, said: “We are excited to add Suracell to our family of customers. We believe Suracell’s scientifically validated formulas are an ideal fit for the unique properties of AC-11, including natural DNA repair, immune enhancement and inhibition of pro-inflammatory agents. The licensing relationship we are entering into today will allow both companies to expand significantly their respective businesses and market penetration.